Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03268993 · ClinicalTrials.gov registry record · NA
Effects of Avmacol® in the Oral Mucosa of Patients Following Curative Treatment for Tobacco-related Head and Neck Cancer
A NA study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT03268993 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 6 participants.
The verdict
NCT03268993, a NA study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
Avmacol is an over-the-counter dietary supplement containing broccoli seed and sprout extracts in tablet form, hypothesized to activate protective cellular pathways including detoxication. In this study, participants who have been curatively treatment for head and neck cancer, will take Avmacol twice a day for 3 months.
Interventions
- DIETARY_SUPPLEMENT Avmacol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2018-07-27 |
| Est. Completion | 2019-07-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03268993
The ClinicalTrials.gov registry entry for NCT03268993 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Avmacol is the first listed.
NCT03268993 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03268993 about?
NCT03268993 is a clinical study titled "Effects of Avmacol® in the Oral Mucosa of Patients Following Curative Treatment for Tobacco-related Head and Neck Cancer". Avmacol is an over-the-counter dietary supplement containing broccoli seed and sprout extracts in tablet form, hypothesized to activate protective cellular pathways including detoxication. In this study, participants who have been curatively treatment for head and neck cancer, will take Avmacol twic...
What is the current status of trial NCT03268993?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2018-07-27. Estimated completion is 2019-07-22.
What interventions are being tested in trial NCT03268993?
The interventions under investigation include: Avmacol (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03268993?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.